Ichnos Sciences has three sites—a biologics and early discovery research center in Lausanne, Switzerland; a biologics manufacturing and process sciences center in La Chaux-de-Fonds, Switzerland; and company headquarters in the United States in New York, New York.
As the heart of our biologics innovation, our Research Centers in Lausanne and La Chaux-de-Fonds focus on the discovery and development of new biological entities (NBEs) and are home to Ichnos’ groundbreaking BEAT® platform and a world-class, GMP-certified manufacturing line. Both Swiss research centers also house a full suite of in-house capabilities necessary for the discovery and development of new investigational biologics, from inception—including cell-line development, bioassay development, and antibody engineering—through preclinical and early clinical studies.
Serving as the base of operations for the organization, corporate headquarters for Ichnos Sciences, located in New York, includes the clinical sciences and development teams.
The link above is provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.